New Zealand markets open in 1 hour 3 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
425.05-5.90 (-1.37%)
As of 03:56PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 35.77B
Enterprise value 36.79B
Trailing P/E 45.70
Forward P/E 41.84
PEG ratio (5-yr expected) 3.59
Price/sales (ttm)10.30
Price/book (mrq)32.70
Enterprise value/revenue 10.47
Enterprise value/EBITDA 31.65

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 323.63%
S&P500 52-week change 313.12%
52-week high 3564.74
52-week low 3317.06
50-day moving average 3489.98
200-day moving average 3480.77

Share statistics

Avg vol (3-month) 3455.35k
Avg vol (10-day) 3423.07k
Shares outstanding 583.01M
Implied shares outstanding 683.01M
Float 882.13M
% held by insiders 10.92%
% held by institutions 191.32%
Shares short (14 Sept 2023) 42.46M
Short ratio (14 Sept 2023) 45.99
Short % of float (14 Sept 2023) 43.33%
Short % of shares outstanding (14 Sept 2023) 42.96%
Shares short (prior month 14 Aug 2023) 42.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 22.52%
Operating margin (ttm)29.82%

Management effectiveness

Return on assets (ttm)23.91%
Return on equity (ttm)102.06%

Income statement

Revenue (ttm)3.51B
Revenue per share (ttm)42.31
Quarterly revenue growth (yoy)9.70%
Gross profit (ttm)2B
Net income avi to common (ttm)791.44M
Diluted EPS (ttm)9.45
Quarterly earnings growth (yoy)69.90%

Balance sheet

Total cash (mrq)132.84M
Total cash per share (mrq)1.6
Total debt (mrq)1.16B
Total debt/equity (mrq)105.64%
Current ratio (mrq)1.33
Book value per share (mrq)13.17

Cash flow statement

Operating cash flow (ttm)746.65M
Levered free cash flow (ttm)511.52M